---
figid: PMC5265918__medi-95-e4906-g009
figtitle: Atorvastatin inhibits insulin synthesis by inhibiting the Ras complex (Ras/Raf/extracellular
  signal-regulated kinase/CREB) in INS-1 cells
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC5265918
filename: medi-95-e4906-g009.jpg
figlink: /pmc/articles/PMC5265918/figure/F9/
number: F9
caption: Atorvastatin inhibits insulin synthesis by inhibiting the Ras complex (Ras/Raf/extracellular
  signal-regulated kinase/CREB) in INS-1 cells. HMG-CoA reductase inhibitor inhibited
  Ras proteins by inhibiting the generation of farnesyl pyrophosphate ester, and reduced
  the phosphorylation of a series of downstream substrates, such as Raf-1 kinase,
  mitogen-activated protein kinase (MAPK) kinase, and MAPK, p90rsk. Inhibition of
  MAPK and p90rsk activation further inhibited the phosphorylation of nuclear transcription
  factor CREB and then influenced the binding quantity of CREB and cAMP response element,
  thereby inhibiting the activity of insulin promoter. CREB = cAMP response element-binding
  protein, HMG-COA = 3-hydroxy-3-methyl glutaryl coenzyme A.
papertitle: Atorvastatin inhibits insulin synthesis by inhibiting the Ras/Raf/ERK/CREB
  pathway in INS-1 cells.
reftext: Hongxi Sun, et al. Medicine (Baltimore). 2016 Sep;95(39):e4906.
year: '2016'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9768341
figid_alias: PMC5265918__F9
figtype: Figure
redirect_from: /figures/PMC5265918__F9
ndex: 4666230c-debf-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5265918__medi-95-e4906-g009.html
  '@type': Dataset
  description: Atorvastatin inhibits insulin synthesis by inhibiting the Ras complex
    (Ras/Raf/extracellular signal-regulated kinase/CREB) in INS-1 cells. HMG-CoA reductase
    inhibitor inhibited Ras proteins by inhibiting the generation of farnesyl pyrophosphate
    ester, and reduced the phosphorylation of a series of downstream substrates, such
    as Raf-1 kinase, mitogen-activated protein kinase (MAPK) kinase, and MAPK, p90rsk.
    Inhibition of MAPK and p90rsk activation further inhibited the phosphorylation
    of nuclear transcription factor CREB and then influenced the binding quantity
    of CREB and cAMP response element, thereby inhibiting the activity of insulin
    promoter. CREB = cAMP response element-binding protein, HMG-COA = 3-hydroxy-3-methyl
    glutaryl coenzyme A.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Shc
  - Myb
  - Pi3K21B
  - Taf5
  - drk
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Sos
  - l(1)G0020
  - Taf4
  - Rpn2
  - Sap-r
  - ras
  - Ras64B
  - Ras85D
  - Raf
  - Pdk1
  - Dsor1
  - Mtk
  - Akt
  - MKP-4
  - p38b
  - rl
  - CrebB
  - CrebA
  - mirr
  - MSX2
  - SHC1
  - SHC2
  - SHC3
  - SHC4
  - PIK3R1
  - PIK3R2
  - ARHGEF7
  - CBFA2T2
  - PPP1R13B
  - PPP1R12C
  - GRB2
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - XYLT2
  - SOS1
  - SOS2
  - CUX1
  - SART3
  - KRAS
  - HRAS
  - NRAS
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - PDK1
  - PDPK1
  - PDK2
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - AKT1
  - AKT2
  - AKT3
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - RPS6KA1
  - RPS6KA2
  - RPS6KA3
  - RPS6KA4
  - RPS6KA5
  - RPS6KA6
  - CREB1
  - CREB3
  - CREB5
  - CREB3L1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREM
  - ATF1
  - ATF2
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
